Mitochondrial Function
Both compounds are studied in mitochondrial models from different angles.

Mitochondrial peptide + coenzyme · 110 mg lyophilized
Get an email when MOTS-c / NAD+ is back
Leave your email and we will send one note the moment it is back in stock.
One email when it restocks, plus occasional Eon updates. Unsubscribe anytime.
Free Shipping on orders over $200
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
Researchers also added
Research use only.
This is a blend. MOTS-c and NAD+ are combined in a single 110 mg vial, 10 mg and 100 mg respectively. The two are not the same class of molecule: MOTS-c is a 16 amino acid peptide encoded in the mitochondrial genome and studied for AMPK signalling, while NAD+ is a coenzyme that carries electrons between reactions and is studied in mitochondrial metabolism, cell signalling and DNA repair. The combination has not been characterised as a single formulation.
Mitochondrial-derived peptide + pyridine dinucleotide coenzyme (10 mg + 100 mg)
The numbers that define MOTS-c / NAD+ and how it is being studied. For laboratory research use only.
MOTS-c · NAD+
10 mg MOTS-c + 100 mg NAD+
Metabolic regulator
The pathways MOTS-c / NAD+ acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.
MOTS-c is a mitochondrial-derived peptide encoded in the mitochondrial genome. AMPK pathway activation and metabolic-regulation endpoints are the characterised readouts.
NAD+ is a coenzyme present in every living cell. It carries electrons between reactions, and studies have measured its role in mitochondrial metabolism, cell signalling and DNA repair.
The vial pairs a signalling peptide with a metabolic cofactor. The two are characterised separately and no interaction data exists for the pair.
The main areas MOTS-c / NAD+ is being studied for - and the study-reported figures behind them.
Both compounds are studied in mitochondrial models from different angles.
MOTS-c is characterised for AMPK-pathway activation in metabolic models.
NAD+ is a standard cofactor in electron-transfer and redox assay work.
One vial holds both compounds under matched handling.
An interactive 3D model rendered from the compound record - rotate and explore its structure.
Molecular model
| Components | MOTS-c + NAD+ |
| Content | 110 mg per vial (10 mg MOTS-c, 100 mg NAD+) |
| MOTS-C | 16-amino acid mitochondrial-derived peptide |
| NAD+ | Pyridine dinucleotide coenzyme, CAS 53-84-9 |
| Form | Lyophilized powder blend |
| Purity | ≥99% by HPLC |
| Appearance | White to off-white powder |
| Solubility | Water-soluble |
| Storage | -20°C, protected from light |
| Classification | Research use only |
They sit on the same subject from different sides: MOTS-c is a mitochondrial-derived signalling peptide, NAD+ is the coenzyme that carries electrons through mitochondrial metabolism. One vial holds both under matched handling.
No. NAD+ is a pyridine dinucleotide coenzyme, not a peptide. It is included here as the cofactor arm of the blend and is characterised as a small molecule rather than by amino acid sequence.
No. Each compound is characterised separately and no interaction data exists for the pair.
The separate products let you control each quantity independently and are offered in several sizes. This vial fixes the ratio at 10 mg and 100 mg.
Each lot is analysed by reverse-phase HPLC and released at ≥99%, with a Certificate of Analysis.
Store lyophilized at -20°C for long-term stability, protected from light and moisture, and avoid repeated freeze-thaw cycles.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.